BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2024 6:31:20 AM | Browse: 83 | Download: 270
 |
Received |
|
2024-03-29 14:16 |
|
Peer-Review Started |
|
2024-03-29 14:16 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-05-06 03:28 |
|
Revised |
|
2024-05-20 17:56 |
|
Second Decision |
|
2024-06-21 02:39 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-06-21 07:07 |
|
Articles in Press |
|
2024-06-21 07:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-06-25 23:43 |
|
Typeset the Manuscript |
|
2024-07-24 07:54 |
|
Publish the Manuscript Online |
|
2024-08-29 06:31 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Retrospective Study |
| Article Title |
SCN1A rs6732655A/T polymorphism: Diagnostic and therapeutic insights for drug-resistant epilepsy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Aroop Viswas, Pradeep K Dabla, Dharmsheel Shrivastav, Swapan Gupta, Manisha Yadav, Subhash Yadav and Bidhan Chandra Koner |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Pradeep K Dabla, MD, Professor, Department of Biochemistry, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, 1, Jawaharlal Nehru Marg, 64 Khamba Raj Ghat, New Delhi 110002, Delhi, India. pradeep_dabla@yahoo.com |
| Key Words |
Epilepsy; Drug resistance; SCN1A gene; Pro-inflammatory cytokines; Genetic factors |
| Core Tip |
Epilepsy poses a substantial global health burden due to its recurrent seizures, with a subset of patients proving resistant to current treatments, leading to increased mortality and decreased quality of life. Genetic factors, including SCN1A gene variants, and their pro-inflammatory cytokines response [interleukin (IL)-1β, IL-6, and high mobility group box 1 protein (HMGB1)], play crucial roles in drug resistance. This study investigates the correlation between SCN1A gene variants (rs6732655A/T) and drug resistance in epilepsy, confirming higher levels of IL-1β, IL-6, and HMGB1 in drug-resistant cases and suggesting specific genotypes (AA and AT) as potential biomarkers for oxidative stress and neuroinflammation in drug-resistant idiopathic epilepsy. |
| Publish Date |
2024-08-29 06:31 |
| Citation |
<p>Viswas A, Dabla PK, Shrivastav D, Gupta S, Yadav M, Yadav S, Koner BC. SCN1A rs6732655A/T polymorphism: Diagnostic and therapeutic insights for drug-resistant epilepsy. <i>World J Exp Med</i> 2024; 14(3): 94999</p> |
| URL |
https://www.wjgnet.com/2220-315x/full/v14/i3/94999.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v14.i3.94999 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
